

Adthyza has been discontinued in 2025. Get the latest update on NDT thyroid medication availability, costs, and alternatives for patients in 2026.
If you've been searching for Adthyza at your pharmacy, we need to be upfront with you: Adthyza is no longer being manufactured. Azurity Pharmaceuticals officially discontinued the drug in late November 2025, and any remaining pharmacy inventory has been depleted.
But the story doesn't end there. The entire natural desiccated thyroid (NDT) medication landscape is shifting in ways that affect millions of hypothyroid patients. Here's everything you need to know going into 2026.
Adthyza is not technically "in shortage" — it's been permanently discontinued. This is an important distinction. A drug shortage means supply is temporarily limited. A discontinuation means the manufacturer has stopped making the product entirely, with no plans to bring it back.
Adthyza was first marketed in February 2023 and had a market life of less than three years before Azurity Pharmaceuticals pulled the plug.
Several factors contributed to Adthyza's disappearance:
For the full explanation, read: Why Is Adthyza So Hard to Find?
The FDA's August 2025 announcement didn't just affect Adthyza — it threatens all NDT products:
The FDA has given manufacturers a 12-month transition period from the August 2025 announcement. Patient advocacy groups are fighting to preserve access, but the timeline and outcome remain uncertain.
With Adthyza gone and the NDT market shrinking, understanding current pricing is crucial:
Adthyza's former price was $29-$38/month, making it competitive with NP Thyroid. If cost is a major concern as you transition, see our savings guide: How to Save Money on Thyroid Medication in 2026.
While no direct replacement for Adthyza has emerged, there are some developments worth noting:
If you've been switched to Armour Thyroid, NP Thyroid, or another thyroid medication and need to find it in stock, here are your best steps:
For a detailed walkthrough, read: How to Find Thyroid Medication in Stock Near You.
Here's your action plan:
The loss of Adthyza is part of a larger upheaval in the thyroid medication landscape. For the millions of Americans who rely on NDT products, 2026 is a year of uncertainty — but also a year where staying informed and proactive matters more than ever.
We'll continue to update this page as the situation evolves. In the meantime, use Medfinder to find your thyroid medication in stock, and explore our other resources:
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.